The Study
Spermidine preserves cardiac systolic function in estrogen-deprived rats with accelerated aging via metabolic and mitochondrial reprogramming
This study tested a substance called spermidine in rats that were made to age faster and lose a hormone similar to estrogen. It found that the rats' hearts worked better after taking spermidine. But this doesn't mean it will work the same way in people — it's just a clue for scientists to explore further.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
When female rats lose estrogen and age fast, their hearts get weak and stressed. Giving them spermidine—a substance found in foods like wheat germ—helped their hearts pump better and reduced damage.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 519 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this suggests spermidine could help postmenopausal women avoid heart failure without estrogen’s cancer risks, but it doesn’t reverse aging or fix insulin resistance.
- 2Spermidine improved heart pumping (ejection fraction) by ~15-20%, cut mitochondrial ROS and heart tissue damage (MDA) by ~30-40%, and reduced cell death (TUNEL+) by ~50%—similar to estrogen.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Scientific Reports
Year
2026
Authors
W. Kaorop, C. Maneechote, W. Pratchayasakul, S. Kumfu, B. Arunsak, Apisek Kongkaew, S. Chattipakorn, N. Chattipakorn
Related Content
Claims (6)
In female Wistar rats with accelerated aging and low estrogen, spermidine decreases mitochondrial fission by reducing a specific chemical modification on the Drp1 protein, while leaving mitochondrial fusion proteins unchanged.
In female rats with accelerated aging and estrogen loss, daily spermidine supplementation maintained heart pumping function, lowered oxidative stress markers in heart mitochondria, reduced lipid damage in heart tissue, and decreased heart cell death.
In female Wistar rats with accelerated aging and low estrogen, spermidine lowered markers of oxidative stress and inflammation in the heart, but did not lower tumor necrosis factor-alpha or reverse signs of cellular aging in heart tissue.
In female Wistar rats with accelerated aging and low estrogen, spermidine decreases heart cell death by lowering the Bax/Bcl-2 protein ratio and reducing TUNEL-positive heart cells, without changing markers of cellular aging.
Spermidine triggers the selective removal of damaged mitochondria through a cellular cleanup process called mitophagy, which preserves the functional balance of mitochondria in cells.
In female Wistar rats with accelerated aging and low estrogen, spermidine treatment lowers cardiac mitochondrial reactive oxygen species and stabilizes mitochondrial membrane potential to the same extent as estrogen therapy, resulting in improved mitochondrial energy production.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.